Johnson & Johnson Innovation Invests In Thirty Madison, Direct-To-Consumer Telehealth Company

On August 14, 2020, Johnson & Johnson Innovation – JJDC, Inc. announced an investment in Thirty Madison, a digital health company that markets direct-to-consumer telehealth services and medications for hair loss, migraines, and acid reflux. The $47 million Series B funding round was led by Polaris Partners. The size of the JJDC investment was not disclosed. Existing investors Maveron and Northzone also participated in the funding round. Thirty Madison has raised a total of $70 million to date.

Thirty Madison was founded in 2017. It has three portfolio brands—Keeps, Cove, and Evens. Each brand platform offers individualized health . . .